Medical sterilization company Sterilis said yesterday it tapped former Nanosphere (NSDQ:NSPH) chief exec Michael McGarrity as its new CEO. McGarrity held the CEO position at Nanosphere from February 2013 to last June when he oversaw the company’s $76.9 million acquisition by Luminex (NSDQ:LMNX). Prior to his time as head of Nanosphere, McGarrity held positions in sales, marketing […]
Nanosphere
Luminex closes Nanosphere buy
Luminex (NSDQ:LMNX) said today that it closed its buy of Nanosphere (NSDQ:NSPH) through the purchase of 45.3 million shares at $1.70 per share, offering up $76.9 million for the company. The company said that in addition to the purchased shares, it sent notices of guaranteed deliver with respect to 953,173 shares, and that the merger was completed […]
Luminex raises Nanosphere offer to $102m
Luminex (NSDQ:LMNX) said today that a 3rd-party offer for Nanosphere (NSDQ:NSPH) prompted it to raise its own $83 million bid for the company and its Verigene molecular diagnostics technology. Last week Luminex offered $1.35 pe share for Nanosphere and said it would also pay off some $25 million of Nanosphere’s debt. Today the company said a $1.50-per-share bid from an […]
Luminex pays $83m for Nanosphere
Luminex (NSDQ:LMNX) agreed to pay a total of $83 million to acquire Nanosphere (NSDQ:NSPH) and its Verigene molecular diagnostics technology. The $1.35-per-share, all-cash deal consists of a 15-day tender offer for NSPH shares by Luminex, followed by a merger to buy up and untendered shares, the companies said. It’s expected to close during the 2nd quarter, they […]
New JenaValve CEO is Boston Scientific vet Carr-Brendel | Personnel Moves
JenaValve said this week that it tapped Victoria Carr-Brendel, former general manager of Boston Scientific‘s (NYSE:BSX) Bayer Interventional business, as its new chief executive officer. Carr-Brendel will replace Jan Keltjens, who served as interim CEO of the transcatheter aortic valve repair-focused company since January 2015. Keltjens will remain with the company as chairman of the board, JenaValve said. […]
Nanosphere might go up on the auction block
A year after closing on a $30 million offering, Nanosphere said yesterday that it’s hired an investment bank to examine the proverbial "strategic alternatives," including a possible sale of the molecular diagnostics technology business.
Nanosphere closes $30M offering
Nanosphere (NSDQ:NSPH) pulled down $30.2 million in a public offering of some 17.3 million shares, including a substantial over-allotment snapped up by the offering’s underwriters.
Nanosphere prices $26M offering | Wall Street Beat
Nanosphere (NSDQ:NSPH) said it priced a public offering of 15 million shares at $1.75 apiece, aiming to drum up a minimum of $26.3 million for its molecular diagnostics technology.
